Nilendu C. Purandare

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 261 publications

Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.

Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: January 29, 2026

Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 28, 2026

Role of Gallium 68 fibroblast activation protein inhibitor PET/CT in the initial evaluation of gastric adenocarcinoma: a single-institution retrospective study.

Role of Gallium 68 fibroblast activation protein inhibitor PET/CT in the initial evaluation of gastric adenocarcinoma: a single-institution retrospective study.

Journal: Nuclear medicine communications

Published: August 24, 2025

Persistent Fluorodeoxyglucose Uptake on Post-Definitive Radiotherapy PET/CT Evaluation Predicts Poor Survival in Pediatric Metastatic Ewing Sarcoma: A Single-Center Cohort Study.

Persistent Fluorodeoxyglucose Uptake on Post-Definitive Radiotherapy PET/CT Evaluation Predicts Poor Survival in Pediatric Metastatic Ewing Sarcoma: A Single-Center Cohort Study.

Journal: Cancer medicine

Published: August 01, 2025

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Journal: BMC cancer

Published: July 28, 2025

First-in-India experience with 90Y-BhabhaSphere: an indigenous 90Y-TheraSphere biosimilar for transarterial radioembolization of hepatic malignancies.

First-in-India experience with 90Y-BhabhaSphere: an indigenous 90Y-TheraSphere biosimilar for transarterial radioembolization of hepatic malignancies.

Journal: The British journal of radiology

Published: May 23, 2025

Long-term outcomes with non-dose dense chemotherapy for Ewing sarcoma - a follow up of the cohort treated with EFT-2001 protocol.

Long-term outcomes with non-dose dense chemotherapy for Ewing sarcoma - a follow up of the cohort treated with EFT-2001 protocol.

Journal: Ecancermedicalscience

Published: April 27, 2025

Positron emission tomography imaging biomarker and artificial intelligence for the characterization of solitary pulmonary nodule.

Positron emission tomography imaging biomarker and artificial intelligence for the characterization of solitary pulmonary nodule.

Journal: Frontiers in nuclear medicine

Published: April 14, 2025

Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in India.

Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in India.

Journal: JCO global oncology

Published: February 06, 2025

Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer.

Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer.

Journal: BJR open

Published: December 21, 2024

Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India.

Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India.

Journal: Ecancermedicalscience

Published: October 28, 2024

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.

Journal: Exploration of targeted anti-tumor therapy

Published: September 16, 2024

Showing 1-12 of 261

Last Updated: 09/26/2026